Third dose of the BNT162b2 vaccine results in very high levels of neutralizing antibodies against SARS-CoV-2: Results of a prospective study in 150 health professionals in Greece

AMERICAN JOURNAL OF HEMATOLOGY

WILEY

1. IEMBITHEK (Greece)